Ravi S. Chari, SVP-Clinical Excellence at HCA Healthcare, Inc. (HCA), sold 32,477 shares at $103.08 ($3.3M) on 2018-02-01, disclosed to the SEC on 2018-02-02.
Seasonal sale ($3.3M) by SVP-Clinical Excellence — this insider has traded HCA in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $101.16 | 9,937 | $1.0M | 30.5% |
| 2 | $101.50 | 10,000 | $1.0M | 30.8% |
| 3 | $103.08 | 568 | $59K | 1.8% |
| 4 | $103.08 | 568 | $59K | 1.8% |
| 5 | $102.01 | 5,702 | $582K | 17.6% |
| 6 | $102.01 | 5,702 |
| $582K |
| 17.6% |
| Total | $101.63 avg | 32,477 | $3.3M | 100% |
| Filing → |
| HCA | SELL | 2015-08-07 | $1.0M | — | Filing → |